Search Results 521-530 of 17338 for alopecia
... alopecia and fatigue; No craniotomy within 28 days of registration. Not pregnant and not nursing. A female of childbearing potential is a sexually mature ...
... alopecia) due to therapy administered prior to the initiation of study drug dosing. Nursing or pregnant. Known allergy or hypersensitivity to any of the ...
Has not recovered from clinically relevant non-hematologic CTCAE grade ≥ 3 toxicity of previous anticancer therapy prior to randomization (excluding alopecia, ...
... alopecia or Grade 2 peripheral neuropathy prior to randomization. Patients who are not candidates for adjuvant chemotherapy or decline chemotherapy are ...
... alopecia and peripheral neuropathy. Have adequate organ function, including: Hematologic: absolute neutrophil count ≥1.5 × 10⁹/Liter (L), platelets ≥100 ...
EXCEPTIONS: Stable chronic conditions (≤ grade 2) that are not expected to resolve (such as neuropathy, myalgia, alopecia, prior therapy-related ...
Hydrochlorothiazide is also used to treat fluid retention (edema) that is caused by congestive heart failure, severe liver disease (cirrhosis), kidney disease, ...
Treatment for swallowing disorders depends on the cause of the problem, making it essential to get the correct diagnosis. Jessica Gregor, a board-certified ...
Recovery to ≤ Grade 1 or baseline of any toxicities due to prior systemic treatments, excluding alopecia. Women of child bearing potential (WCBP), defined ...
Patient must have recovered from any adverse events due to prior anti-cancer therapy (i.e., have no residual toxicities > grade 1 with the exception of alopecia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.